Literature DB >> 14605120

Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease.

Mohamed A Karmali1, Mariola Mascarenhas, Songhai Shen, Kim Ziebell, Shelley Johnson, Richard Reid-Smith, Judith Isaac-Renton, Clifford Clark, Kris Rahn, James B Kaper.   

Abstract

The distribution of EDL 933 O island 122 (OI-122) was investigated in 70 strains of Verocytotoxin-producing Escherichia coli (VTEC) of multiple serotypes that were classified into five "seropathotypes" (A through E) based on the reported occurrence of serotypes in human disease, in outbreaks, and/or in the hemolytic-uremic syndrome (HUS). Seropathotype A comprised 10 serotype O157:H7 and 3 serotype O157:NM strains. Seropathotype B (associated with outbreaks and HUS but less commonly than serotype O157:H7) comprised three strains each of serotypes O26:H11, O103:H2, O111:NM, O121:H19, and O145:NM. Seropathotype C comprised four strains each of serotypes O91:H21 and O113:H21 and eight strains of other serotypes that have been associated with sporadic HUS but not typically with outbreaks. Seropathotype D comprised 14 strains of serotypes that have been associated with diarrhea but not with outbreaks or HUS, and seropathotype E comprised animal VTEC strains of serotypes not implicated in human disease. All strains were tested for four EDL 933 OI-122 virulence genes (Z4321, Z4326, Z4332, and Z4333) by PCR. Negative PCRs were confirmed by Southern hybridization. Overall, 28 (40%) strains contained OI-122 (positive for all four virulence genes), 27 (38.6%) contained an "incomplete" OI-122 (positive for one to three genes), and 15 (21.4%) strains did not contain OI-122. The seropathotype distribution of complete OI-122 was as follows: 100% for seropathotype A, 60% for B, 36% for C, 15% for D, and 0% for E. The differences in the frequency of OI-122 between seropathotypes A, B, and C (associated with HUS) and seropathotypes D and E (not associated with HUS) and between seropathotypes A and B (associated with epidemic disease) and seropathotypes C, D, and E (not associated with epidemic disease) were highly significant (P < 0.0001).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14605120      PMCID: PMC262514          DOI: 10.1128/JCM.41.11.4930-4940.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  57 in total

1.  Waterborne outbreak of gastroenteritis associated with a contaminated municipal water supply, Walkerton, Ontario, May-June 2000.

Authors: 
Journal:  Can Commun Dis Rep       Date:  2000-10-15

2.  Identification of a novel genetic locus that is required for in vitro adhesion of a clinical isolate of enterohaemorrhagic Escherichia coli to epithelial cells.

Authors:  L Nicholls; T H Grant; R M Robins-Browne
Journal:  Mol Microbiol       Date:  2000-01       Impact factor: 3.501

3.  The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings.

Authors:  N Banatvala; P M Griffin; K D Greene; T J Barrett; W F Bibb; J H Green; J G Wells
Journal:  J Infect Dis       Date:  2001-03-01       Impact factor: 5.226

4.  Genome sequence of enterohaemorrhagic Escherichia coli O157:H7.

Authors:  N T Perna; G Plunkett; V Burland; B Mau; J D Glasner; D J Rose; G F Mayhew; P S Evans; J Gregor; H A Kirkpatrick; G Pósfai; J Hackett; S Klink; A Boutin; Y Shao; L Miller; E J Grotbeck; N W Davis; A Lim; E T Dimalanta; K D Potamousis; J Apodaca; T S Anantharaman; J Lin; G Yen; D C Schwartz; R A Welch; F R Blattner
Journal:  Nature       Date:  2001-01-25       Impact factor: 49.962

5.  Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12.

Authors:  T Hayashi; K Makino; M Ohnishi; K Kurokawa; K Ishii; K Yokoyama; C G Han; E Ohtsubo; K Nakayama; T Murata; M Tanaka; T Tobe; T Iida; H Takami; T Honda; C Sasakawa; N Ogasawara; T Yasunaga; S Kuhara; T Shiba; M Hattori; H Shinagawa
Journal:  DNA Res       Date:  2001-02-28       Impact factor: 4.458

6.  Complete nucleotide sequence and analysis of the locus of enterocyte Effacement from rabbit diarrheagenic Escherichia coli RDEC-1.

Authors:  C Zhu; T S Agin; S J Elliott; L A Johnson; T E Thate; J B Kaper; E C Boedeker
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

7.  Cattle can be a reservoir of sorbitol-fermenting shiga toxin-producing Escherichia coli O157:H(-) strains and a source of human diseases.

Authors:  M Bielaszewska; H Schmidt; A Liesegang; R Prager; W Rabsch; H Tschäpe; A Cízek; J Janda; K Bláhová; H Karch
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

8.  Iha: a novel Escherichia coli O157:H7 adherence-conferring molecule encoded on a recently acquired chromosomal island of conserved structure.

Authors:  P I Tarr; S S Bilge; J C Vary; S Jelacic; R L Habeeb; T R Ward; M R Baylor; T E Besser
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

9.  A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation.

Authors:  J M Klapproth; I C Scaletsky; B P McNamara; L C Lai; C Malstrom; S P James; M S Donnenberg
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

10.  PulseNet: the molecular subtyping network for foodborne bacterial disease surveillance, United States.

Authors:  B Swaminathan; T J Barrett; S B Hunter; R V Tauxe
Journal:  Emerg Infect Dis       Date:  2001 May-Jun       Impact factor: 6.883

View more
  184 in total

1.  Evidence for a hybrid genomic island in verocytotoxin-producing Escherichia coli CL3 (serotype O113:H21) containing segments of EDL933 (serotype O157:H7) O islands 122 and 48.

Authors:  Songhai Shen; Mariola Mascarenhas; Kris Rahn; James B Kaper; Mohamed A Karmali; Mohamed A Karmal
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

2.  Non-O157 verotoxigenic Escherichia coli and beef: a Canadian perspective.

Authors:  Alexander Gill; Colin O Gill
Journal:  Can J Vet Res       Date:  2010-07       Impact factor: 1.310

3.  Seropathotypes, Phylogroups, Stx subtypes, and intimin types of wildlife-carried, shiga toxin-producing escherichia coli strains with the same characteristics as human-pathogenic isolates.

Authors:  Azucena Mora; Cecilia López; Ghizlane Dhabi; Ana M López-Beceiro; Luís E Fidalgo; Eduardo A Díaz; Carlos Martínez-Carrasco; Rosalía Mamani; Alexandra Herrera; Jesús E Blanco; Miguel Blanco; Jorge Blanco
Journal:  Appl Environ Microbiol       Date:  2012-02-03       Impact factor: 4.792

4.  Serotypes and virulence profiles of non-O157 Shiga toxin-producing Escherichia coli isolates from bovine farms.

Authors:  Aine Monaghan; Brian Byrne; Séamus Fanning; Torres Sweeney; David McDowell; Declan J Bolton
Journal:  Appl Environ Microbiol       Date:  2011-10-14       Impact factor: 4.792

5.  Association of virulence genotype with phylogenetic background in comparison to different seropathotypes of Shiga toxin-producing Escherichia coli isolates.

Authors:  Jean Pierre Girardeau; Alessandra Dalmasso; Yolande Bertin; Christian Ducrot; Séverine Bord; Valérie Livrelli; Christine Vernozy-Rozand; Christine Martin
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

6.  Applicability of phylogenetic methods for characterizing the public health significance of verocytotoxin-producing Escherichia coli strains.

Authors:  Kim Ziebell; Paulina Konczy; Irene Yong; Shelley Frost; Mariola Mascarenhas; Andrew M Kropinski; Thomas S Whittam; Susan C Read; Mohamed A Karmali
Journal:  Appl Environ Microbiol       Date:  2007-12-28       Impact factor: 4.792

7.  Association of clustered regularly interspaced short palindromic repeat (CRISPR) elements with specific serotypes and virulence potential of shiga toxin-producing Escherichia coli.

Authors:  Magaly Toro; Guojie Cao; Wenting Ju; Marc Allard; Rodolphe Barrangou; Shaohua Zhao; Eric Brown; Jianghong Meng
Journal:  Appl Environ Microbiol       Date:  2013-12-13       Impact factor: 4.792

Review 8.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

9.  Production of verotoxin and distribution of O islands 122 and 43/48 among verotoxin-producing Escherichia coli O103:H2 isolates from cattle and humans.

Authors:  Musafiri Karama; Roger P Johnson; Robert Holtslander; Carlton L Gyles
Journal:  Appl Environ Microbiol       Date:  2008-11-07       Impact factor: 4.792

10.  Novel repressor of Escherichia coli O157:H7 motility encoded in the putative fimbrial cluster OI-1.

Authors:  Sarah E Allison; Uma Silphaduang; Mariola Mascarenhas; Paulina Konczy; Quyen Quan; Mohamed Karmali; Brian K Coombes
Journal:  J Bacteriol       Date:  2012-07-27       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.